These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10048978)

  • 61. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
    Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
    Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
    Yoshizaki T; Sato H; Maruyama Y; Murono S; Furukawa M; Park CS; Seiki M
    Cancer; 1997 Jan; 79(1):139-44. PubMed ID: 8988738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
    Belkaid A; Fortier S; Cao J; Annabi B
    Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
    Knight CG; Willenbrock F; Murphy G
    FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
    Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
    Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
    Troeberg L; Nagase H
    Curr Protoc Protein Sci; 2004 Nov; Chapter 21():21.16.1-21.16.9. PubMed ID: 18429258
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.
    Llorens A; Vinyals A; Alia P; López-Barcons L; Gonzalez-Garrigues M; Fabra A
    Mol Carcinog; 1997 May; 19(1):54-66. PubMed ID: 9180929
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide.
    Bannikov GA; Karelina TV; Collier IE; Marmer BL; Goldberg GI
    J Biol Chem; 2002 May; 277(18):16022-7. PubMed ID: 11839746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.
    Bonacci G; Schopfer FJ; Batthyany CI; Rudolph TK; Rudolph V; Khoo NK; Kelley EE; Freeman BA
    J Biol Chem; 2011 May; 286(18):16074-81. PubMed ID: 21454668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes.
    Giunciuglio D; Culty M; Fassina G; Masiello L; Melchiori A; Paglialunga G; Arand G; Ciardiello F; Basolo F; Thompson EW
    Int J Cancer; 1995 Dec; 63(6):815-22. PubMed ID: 8847140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Suppression of metastatic potential and up-regulation of gelatinases and uPA in LLC by protracted in vivo treatment with dacarbazine or razoxane.
    Garbisa S; Onisto M; Peron A; Perissin L; Rapozzi V; Zorzet S; Giraldi T
    Int J Cancer; 1997 Sep; 72(6):1056-61. PubMed ID: 9378540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival.
    Walther MM; Kleiner DE; Lubensky IA; Pozzatti R; Nyguen T; Gnarra JR; Hurley K; Venzon D; Linehan WM; Stetler-Stevenson WG
    Urology; 1997 Aug; 50(2):295-301. PubMed ID: 9255309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids.
    Berton A; Rigot V; Huet E; Decarme M; Eeckhout Y; Patthy L; Godeau G; Hornebeck W; Bellon G; Emonard H
    J Biol Chem; 2001 Jun; 276(23):20458-65. PubMed ID: 11278959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cell-matrix interactions in gland development in the lung.
    Infeld MD
    Exp Lung Res; 1997; 23(2):161-9. PubMed ID: 9088925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of differentially expressed gelatinase A in metastatic and non-metastatic subpopulations of tumor cells by target RNA arbitrarily primed polymerase chain reaction (TRAP-PCR).
    Vinyals A; Alía P; Llorens A; Adrover M; Gonzalez-Garrigues M; Masramon L; Peinado MA; Fabra A
    Clin Exp Metastasis; 1998 Oct; 16(7):603-11. PubMed ID: 9932607
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Substrate-dependent activation of thermolysin by salt.
    Oneda H; Muta Y; Inouye K
    Biosci Biotechnol Biochem; 2004 Aug; 68(8):1811-3. PubMed ID: 15322372
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Flow injection analysis for measurement of activity of matrix metalloproteinase-7 (MMP-7).
    Itoh M; Osaki M; Chiba T; Masuda K; Akizawa T; Yoshioka M; Seiki M
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1417-26. PubMed ID: 9226571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oroxin A ameliorates the oleic acid-induced A549 cell injury through the suppression of pyroptosis and degradation of alveolar surfactant.
    Huang J; Chen C; Xie J; Zhai K; Wei S; Cheng X; Zhang R
    An Acad Bras Cienc; 2022; 94(suppl 4):e20211400. PubMed ID: 36477822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.